This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.
Source link
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.
Source link
